In 2025, KFF reported that 19% of employers with 200+ workers and 43% with 5,000+ workers covered GLP-1s for weight loss, and employers are expected to revisit coverage and cost-containment strategies each year as demand remains high
All Zepbound formulations follow the same storage guidelines regardless of whether they came from a pharmacy or as physician samples
Patients with a history of medullary thyroid carcinoma, pancreatitis, or severe GI disease should avoid dual-compound protocols
Golpon et al
Kidney health protection GLP-1s have shown promising results in protecting kidney function, especially in patients with type 2 diabetes and chronic kidney disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Cummings J.L., Atri A., Feldman H.H., Hansson O., Sano M., Knop F.K., et al